A major study has provided new insights into how well different medications work to control type 2 diabetes when used alongside metformin, a commonly prescribed drug for the condition.
The GRADE Study Research Group conducted this research to discover which drug combination is best at keeping blood sugar levels under control.
The study involved 5,047 people with type 2 diabetes from a wide range of backgrounds. Each participant was already taking metformin, and they were randomly assigned to add one of four other diabetes medications to their treatment plan.
These medications were sitagliptin, liraglutide, glimepiride, and insulin glargine. The participants were monitored over a period of four years to see how well the different combinations helped manage blood sugar levels.
The results showed that liraglutide and insulin glargine, when combined with metformin, were the most effective at maintaining blood sugar levels within target ranges.
These two combinations worked better than the other medications, sitagliptin and glimepiride, in controlling blood sugar levels.
This outcome was consistent across all groups, regardless of factors such as age, gender, race, or ethnicity, suggesting that these combinations are broadly effective for many people.
Despite these findings, the study also revealed a significant challenge: about 75% of the participants were unable to maintain optimal blood sugar levels over the long term, regardless of which medication they were using.
This highlights the ongoing difficulties in managing type 2 diabetes, even with effective medication.
One particularly interesting discovery was that participants who took liraglutide experienced fewer heart-related problems, suggesting that this medication may offer additional health benefits beyond blood sugar control.
While the study focused on comparing how well the medications worked, it also emphasized the challenges of long-term diabetes management.
Simply finding the right medication combination is not enough; maintaining healthy blood sugar levels over time requires continuous effort and possibly new approaches.
For healthcare professionals, this research offers valuable guidance. It suggests that combining metformin with either liraglutide or insulin glargine may be a more effective strategy for many patients.
However, the search for better, longer-lasting solutions to manage diabetes is still ongoing, as researchers continue to explore ways to overcome the complexities of this widespread condition.
Published in The New England Journal of Medicine by Dr. Henry Burch and his team, this study not only highlights the effectiveness of specific medication combinations but also underscores the importance of personalized treatment plans.
It calls for continued research to find lasting strategies to manage type 2 diabetes, which remains a challenging condition for millions of people around the world.
If you care about diabetes, please read studies that MIND diet may reduce risk of vision loss disease, and Vitamin D could benefit people with diabetic neuropathic pain.
For more information about diabetes, please see recent studies that Vitamin E could help reduce blood sugar and insulin resistance in diabetes, and results showing eating eggs in a healthy diet may reduce risks of diabetes, high blood pressure.
Copyright © 2024 Knowridge Science Report. All rights reserved.
